DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Magnevist (Gadopentetate) - Disability - Suspected Cause - Side Effect Reports

 
 



Index of reports > Disability (45)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Magnevist (Gadopentetate) disability. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 45   Next >>

Possible Magnevist side effects in 50 year old female

Reported by a consumer/non-health professional from United States on 2012-08-23

Patient: 50 year old female, weighing 95.5 kg (210.2 pounds)

Reactions: Pain, Skin Induration, Skin Hyperpigmentation, Nephrogenic Systemic Fibrosis, Rash, Anxiety, Emotional Distress, Anhedonia, Skin Discolouration, Post Thrombotic Syndrome, Skin Mass, Ocular Icterus, Injury, Depression, Mobility Decreased

Adverse event resulted in: death, disablity

Drug(s) suspected as cause:
Magnevist
    Dosage: unk
    Indication: Cardiac Imaging Procedure
    Start date: 2003-08-12
    End date: 2003-08-12

Magnevist
    Dosage: unk
    Indication: Renal Scan
    Start date: 2003-08-07
    End date: 2003-08-07

Magnevist
    Dosage: unk
    Start date: 2004-02-03
    End date: 2004-02-03

Other drugs received by patient: Clonidine; Sodium Bicarbonate; Calcium Carbonate; Lopressor; Sevelamer Hydrochloride; Atorvastatin; Warfarin Sodium; Rapamune; Epogen; Diltiazem; Benicar



Possible Magnevist side effects in 50 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-02

Patient: 50 year old female, weighing 95.5 kg (210.2 pounds)

Reactions: Pain, Skin Induration, Nephrogenic Systemic Fibrosis, Scleroderma, Rash, Skin Hyperpigmentation, Emotional Distress, Anxiety, Skin Discolouration, Skin Mass, Injury, Scleral Disorder

Adverse event resulted in: death, disablity

Drug(s) suspected as cause:
Magnevist
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2003-08-12
    End date: 2003-08-12

Magnevist
    Dosage: unk
    Indication: Cardiac Imaging Procedure
    Start date: 2003-08-07
    End date: 2003-08-07

Magnevist
    Dosage: unk
    Indication: Renal Scan
    Start date: 2003-08-07
    End date: 2003-08-07

Magnevist
    Dosage: unk
    Start date: 2004-02-03
    End date: 2004-02-03

Magnevist
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2004-02-03
    End date: 2004-02-03

Magnevist
    Dosage: unk
    Start date: 2003-08-12
    End date: 2003-08-12

Other drugs received by patient: Warfarin; Lopressor; Sevelamer; Benicar; Atorvastatin; Rapamune; Diltiazem; Calcium Carbonate; Clonidine; Sodium Bicarbonate; Epogen



Possible Magnevist side effects in 39 year old female

Reported by a physician from United States on 2012-08-01

Patient: 39 year old female

Reactions: Pain, Musculoskeletal Discomfort, Skin Hyperpigmentation, Nephrogenic Systemic Fibrosis, Rash, Skin Induration, Skin Plaque, Anxiety, Arthralgia, Fibrosis, Injury

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Magnevist



Possible Magnevist side effects in 54 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-02

Patient: 54 year old male

Reactions: Pruritus, Muscle Contractions Involuntary, Pain, Abasia, Neuropathic Ulcer, Erythema, Muscle Rigidity, Neuropathy Peripheral, Oedema Peripheral, Musculoskeletal Stiffness, Injury, Fibrosis, Muscle Spasms, Excoriation, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, Emotional Distress, Arthralgia, Mobility Decreased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2000-11-29

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2000-12-12
    End date: 2000-12-12

Optimark

Magnevist

Omniscan

Other drugs received by patient: Epoetin Alfa; Phoslo; Lorazepam; Misoprostol; Cefazolin Sodium; Vitamin E; Vitamin D; Amiodarone Hydrochloride; Lansoprazole; Humulin R; Calcium Acetate; Verapamil HCL; Atacand HCT; Minoxidil; Cytotec



Possible Magnevist side effects in 57 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-06-21

Patient: 57 year old female, weighing 44.0 kg (96.8 pounds)

Reactions: Nephrogenic Systemic Fibrosis

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Omniscan
    Dosage: 15 ml (daily dose), , intravenous
    Indication: Peripheral Vascular Disorder
    Start date: 2006-10-03
    End date: 2006-10-03

Magnevist
    Dosage: 20 ml (daily dose), once, intravenous
    Indication: Acoustic Neuroma
    Start date: 2004-09-30
    End date: 2004-09-30

Omniscan
    Indication: Acoustic Neuroma
    Start date: 2006-10-01
    End date: 2006-10-01

Omniscan
    Dosage: 15 ml (daily dose), , intravenous
    Start date: 2007-10-02
    End date: 2007-10-02

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Dosage: 15 ml (daily dose), , intravenous
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-11-01
    End date: 2005-11-01

Other drugs received by patient: Famotidine; Losartan Potassium; Diazepam; Calcium Carbonate; Alfarol; Vitamin B12; Carvedilol; Aspirin; Adenosine; Warfarin Sodium; Mucodyne



Possible Magnevist side effects in 68 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-06-21

Patient: 68 year old female, weighing 45.6 kg (100.3 pounds)

Reactions: Nephrogenic Systemic Fibrosis

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Omniscan
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2002-12-28
    End date: 2002-12-28

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-02-08
    End date: 2005-02-08

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-05-27
    End date: 2006-05-27

Other drugs received by patient: Calcium Carbonate; Ferrous Citrate; Primperan TAB; Metoprolol Tartrate; Potassium Gluconate TAB; Selbex; Clonazepam; Bepricor



Possible Magnevist side effects in 54 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-14

Patient: 54 year old male

Reactions: Abasia, Pain, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Emotional Distress, Oedema Peripheral, Musculoskeletal Stiffness, Injury, Fibrosis, Mobility Decreased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Magnevist

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2000-12-12
    End date: 2000-12-12

Optimark

Omniscan



Possible Magnevist side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-11

Patient: male, weighing 70.0 kg (154.0 pounds)

Reactions: Nephrogenic Systemic Fibrosis

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Prohance
    Indication: Renal Mass
    Start date: 2003-07-03
    End date: 2003-07-03

Omniscan
    Indication: Liver Disorder
    Start date: 2004-07-13
    End date: 2004-07-13

Omniscan
    Indication: Neck Pain
    Start date: 2004-07-13
    End date: 2004-07-13

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2004-07-13
    End date: 2004-07-13

Prohance
    Indication: Renal Scan
    Start date: 2003-07-03
    End date: 2003-07-03

Omniscan
    Indication: Osteomyelitis
    Start date: 2004-07-13
    End date: 2004-07-13

Contrast Media
    Indication: Decubitus Ulcer
    Start date: 2005-04-14
    End date: 2005-04-14

Magnevist

Prohance
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-04-14
    End date: 2005-04-14

Contrast Media
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-04-14
    End date: 2005-04-14

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2004-07-13
    End date: 2004-07-13

Multihance
    Indication: Diagnostic Procedure

Optimark

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2004-10-15
    End date: 2004-10-15

Other drugs received by patient: Plavix; Iron; Clonidine; Calcitriol; Proamatine; Epogen; Renvela; Cozaar; Calcium Carbonate; Metoprolol Tartrate; Sensipar; Rena-Vite; Phoslo; Hectorol; Renagel; Amlodipine; Fosrenol; Lisinopril; Foltx



Possible Magnevist side effects in 14 year old male

Reported by a physician from Japan on 2012-06-08

Patient: 14 year old male, weighing 48.0 kg (105.6 pounds)

Reactions: Pruritus, Hyperkeratosis, Hyperthermia, Joint Contracture, Pyrexia, Scleroderma, Erythema, Oedema Peripheral, White Blood Cell Count Increased, Pain in Extremity, Rash Papular, Muscle Contracture, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, Collagen Disorder, Hypoproteinaemia, Grip Strength Decreased, Inflammation

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Omniscan
    Dosage: 10 ml (daily dose), once, intravenous
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-12-28
    End date: 2006-12-28

Omniscan
    Dosage: 10 ml (daily dose), once, intravenous
    Start date: 2007-01-12
    End date: 2007-01-12

Omniscan
    Dosage: 10 ml (daily dose), once, intravenous
    Indication: Glaucoma
    Start date: 2006-09-04
    End date: 2006-09-04

Magnevist
    Dosage: 10 ml (daily dose), once, intravenous
    Start date: 2004-12-17
    End date: 2004-12-17

Magnevist
    Dosage: 10 ml (daily dose), once, intravenous
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2004-07-24
    End date: 2004-07-24

Other drugs received by patient: Calcium Carbonate; Calcium Carbonate; Dexamethasone; Allopurinol; Amlodipine; Ferrous Citrate



Possible Magnevist side effects in 50 year old female

Reported by a consumer/non-health professional from United States on 2012-06-06

Patient: 50 year old female

Reactions: Anxiety, Emotional Distress, Pain, Nephrogenic Systemic Fibrosis, Injury

Adverse event resulted in: death, disablity

Drug(s) suspected as cause:
Magnevist
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2003-08-07
    End date: 2003-08-07

Magnevist
    Dosage: unk
    Start date: 2004-02-03
    End date: 2004-02-03

Magnevist
    Dosage: unk
    Start date: 2003-08-12
    End date: 2003-08-12



Possible Magnevist side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-06

Patient: male, weighing 70.0 kg (154.0 pounds)

Reactions: Pruritus, Hyperkeratosis, Pain, Skin Burning Sensation, Skin Hyperpigmentation, Erythema, Joint Stiffness, Skin Discolouration, Joint Range of Motion Decreased, Skin Lesion, Fibrosis, Extremity Contracture, General Physical Health Deterioration, Muscular Weakness, Nephrogenic Systemic Fibrosis, DRY Skin, Hypoaesthesia, Skin Induration, Deformity, Skin Tightness, Paraesthesia, Skin Plaque, Rash Macular, Gait Disturbance, Scar, Mobility Decreased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2005-04-14
    End date: 2005-04-14

Omniscan
    Dosage: 15 ml, unk
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2004-10-15
    End date: 2004-10-15

Prohance
    Dosage: 17 ml, once
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2003-07-03
    End date: 2003-07-03

Magnevist

Omniscan
    Dosage: 30 ml, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2004-07-13
    End date: 2004-07-13

Prohance
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-04-14
    End date: 2005-04-14

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging Abdominal

Optimark

Multihance

Other drugs received by patient: Calcitriol; Plavix; Fosrenol; Sensipar; Clonidine; Renvela; Rena-Vite; Calcium Carbonate; Metoprolol Tartrate; Renagel; Cozaar; Phoslo; Epogen; Hectorol; Iron; Amlodipine; Lisinopril; Proamatine; Foltx



Possible Magnevist side effects in 79 year old male

Reported by a lawyer from United States on 2012-06-05

Patient: 79 year old male, weighing 68.0 kg (149.6 pounds)

Reactions: Muscle Atrophy, Quality of Life Decreased, Joint Contracture, Pain, Joint Stiffness, Fatigue, Joint Range of Motion Decreased, Oedema, Musculoskeletal Stiffness, Fibrosis, Pain in Extremity, General Physical Health Deterioration, Skin Induration, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, Deformity, Skin Tightness, Emotional Distress, Anxiety, Muscle Disorder, Mobility Decreased, Skin Fibrosis, Scar

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Magnevist
    Indication: Fistulogram
    Start date: 2005-11-21
    End date: 2005-11-21

Magnevist
    Start date: 2006-08-16
    End date: 2006-08-16

Magnevist
    Start date: 2006-04-16
    End date: 2006-04-16

Other drugs received by patient: Lipitor; Megestrol Acetate; Aspirin; Terazosin HCL; Rena-Vite [ascorbic Acid,vitamin B Nos]; Colchicine; Phoslo; Lasix; Coumadin; Rocaltrol; Acetaminophen; Atenolol; Prednisone; Aspirin; Isosorbide Mononitrate; Nitroglycerin; Warfarin; Allopurinol; Procardia; Prednisone; Allopurinol; Nephro-Vite [vitamins Nos]; Metoprolol Tartrate



Possible Magnevist side effects in 78 year old male

Reported by a consumer/non-health professional from Japan on 2012-06-01

Patient: 78 year old male, weighing 56.0 kg (123.2 pounds)

Reactions: Joint Range of Motion Decreased, Skin Discolouration, Nephrogenic Systemic Fibrosis, Gait Disturbance, Skin Induration, Blood Creatinine Increased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Magnevist
    Dosage: 10 ml, once
    Indication: Metastases To Lymph Nodes
    Start date: 2008-07-29
    End date: 2008-07-29

Prohance
    Dosage: 26 ml, once
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2008-07-17
    End date: 2008-07-17

Other drugs received by patient: Selbex; Omeprazole; SG Granules; Loxonin; Digoxin; Neurotropin [organ Lysate, Standardized]; Metformin Hydrochloride; Olopatadine HCL; Omeprazole; Unasyn; Antebate; Warfarin Sodium; Lendormin; Adalat CC; Lasix; Strong NEO-Minophagen C; Flomox; Celestamine TAB; Atarax; Zefnart



Possible Magnevist side effects in 78 year old male

Reported by a consumer/non-health professional from Japan on 2012-05-23

Patient: 78 year old male, weighing 56.0 kg (123.2 pounds)

Reactions: Joint Range of Motion Decreased, Skin Discolouration, Gait Disturbance, Skin Induration, Nephrogenic Systemic Fibrosis

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Magnevist
    Dosage: 10 ml, once
    Indication: Diagnostic Procedure
    Start date: 2008-07-29
    End date: 2008-07-29

Prohance
    Dosage: 26 ml, once
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2008-07-17
    End date: 2008-07-17

Other drugs received by patient: Lasix; Strong NEO-Minophagen C; Lendormin; Omeprazole; Neurotropin [organ Lysate, Standardized]; Antebate; Flomox; Warfarin Sodium; Unasyn; Selbex; Olopatadine HCL; Atarax; Loxonin; Omeprazole; SG Granules; Digoxin; Celestamine TAB; Adalat CC; Zefnart; Metfformin Hydrochloride



Possible Magnevist side effects in 63 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-17

Patient: 63 year old male, weighing 61.0 kg (134.2 pounds)

Reactions: Muscle Atrophy, Skin Exfoliation, Pain, Sensory Loss, Scleroderma, Pallor, Anhedonia, Skin Discolouration, Joint Range of Motion Decreased, Musculoskeletal Stiffness, Skin Atrophy, Extremity Contracture, Muscle Contracture, Motor Dysfunction, Muscular Weakness, Skin Disorder, Skin Fragility, DRY Skin, Skin Induration, Nephrogenic Systemic Fibrosis, Hypoaesthesia, Emotional Distress, Burning Sensation, Anxiety, Xerosis, Activities of Daily Living Impaired, Arthralgia, Grip Strength Decreased, Asthenia, Mobility Decreased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Magnevist
    Dosage: unk, once
    Indication: Angiogram
    Start date: 2006-07-17
    End date: 2006-07-17

Magnevist

Other drugs received by patient: Norvasc; Epogen; Vancomycin; Oxycodone HCL; Iron; Calcitonin Salmon; Heparin; Renagel; Lisinopril; Lebacarton; Clindamycin; Colace; Sensipar; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Nephrocaps; Corticosteroids



Possible Magnevist side effects in 52 year old female

Reported by a consumer/non-health professional from United States on 2012-05-04

Patient: 52 year old female, weighing 59.0 kg (129.7 pounds)

Reactions: Soft Tissue Disorder, Joint Contracture, Abasia, Pain, Skin Hyperpigmentation, Muscle Fibrosis, Joint Stiffness, Myosclerosis, Calcification of Muscle, Skin Discolouration, Impaired Self-Care, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Unevaluable Event, Extremity Contracture, Skin Disorder, Skin Hypopigmentation, Nephrogenic Systemic Fibrosis, Skin Induration, Stress, Amnesia, Skin Plaque, Anxiety, Dysphonia, Skin Fibrosis, Scar, Mobility Decreased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Omniscan
    Dosage: unk unk, once
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 1998-06-01
    End date: 1998-06-01

Omniscan
    Dosage: 30 ml, once
    Indication: Nuclear Magnetic Resonance Imaging Thoracic
    Start date: 1999-05-14
    End date: 1999-05-14

Omniscan
    Dosage: unk, once
    Indication: Angiogram
    Start date: 2001-07-20
    End date: 2001-07-20

Magnevist
    Dosage: 20 ml, once
    Indication: Nuclear Magnetic Resonance Imaging Thoracic
    Start date: 2003-09-09
    End date: 2003-09-09

Omniscan
    Dosage: 0.15 mmol/kg
    Start date: 2000-04-18
    End date: 2000-04-18

Omniscan
    Dosage: 30 ml, once
    Indication: Venogram
    Start date: 2000-10-19
    End date: 2000-10-19

Omniscan
    Dosage: 0.1 mmol/kg, unk
    Start date: 2003-10-20
    End date: 2003-10-20

Omniscan
    Dosage: 40 ml, once
    Start date: 2001-10-16
    End date: 2001-10-16

Magnevist
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 1998-06-01
    End date: 1998-06-01

Magnevist
    Dosage: unk
    Start date: 2003-09-25
    End date: 2003-09-25

Omniscan
    Dosage: 50 ml, once
    Start date: 2003-09-30
    End date: 2003-09-30

Magnevist
    Indication: Angiogram

Omniscan
    Dosage: daily dose 40 ml
    Start date: 2002-11-01
    End date: 2002-11-01

Omniscan
    Dosage: 0.2mmol/kg
    Start date: 2003-09-27
    End date: 2003-09-27

Omniscan
    Dosage: 0.1mmol/kg
    Start date: 2003-10-03
    End date: 2003-10-03

Other drugs received by patient: Simvastatin; Coumadin; Avapro; Maxidex; Claforan; Omnipaque 140; Metoprolol Tartrate; Enalapril Maleate; Chlorothiazide; Furosemide; Moduretic 5-50; Cozaar; Lasix; Magnesium Oxide; Potassium Chloride; Benadryl; Nifedipine; Sevelamer; Potassium Chloride; Spironolactone; Epogen; Iron Supplement; Omnipaque 140; Clonidine; Flonase



Possible Magnevist side effects in 43 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-30

Patient: 43 year old male, weighing 118.0 kg (259.6 pounds)

Reactions: Pain in Extremity, General Physical Health Deterioration, Skin Induration, Nephrogenic Systemic Fibrosis, Deformity, Skin Tightness, Emotional Distress, Anxiety, Skin Discolouration, Fibrosis, Depression, Mobility Decreased, Scar

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Omniscan
    Dosage: 20 ml, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-04-25
    End date: 2006-04-25

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Dosage: 20 ml, once
    Start date: 2006-05-21
    End date: 2006-05-21

Other drugs received by patient: Nephrocaps; Losartan Potassium; Aldactone; Insulin; Albumin (Human); Cardizem; Zemplar; Procardia XL; Aranesp; Catapres; Procrit; Phoslo



Possible Magnevist side effects in 63 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-03

Patient: 63 year old male, weighing 61.0 kg (134.2 pounds)

Reactions: Muscle Atrophy, Skin Exfoliation, Pain, Joint Contracture, Sensory Loss, Scleroderma, Pallor, Anhedonia, Joint Range of Motion Decreased, Skin Discolouration, Musculoskeletal Stiffness, Skin Atrophy, Extremity Contracture, Motor Dysfunction, Skin Fragility, Skin Disorder, Muscular Weakness, DRY Skin, Hypoaesthesia, Nephrogenic Systemic Fibrosis, Skin Induration, Emotional Distress, Anxiety, Burning Sensation, Activities of Daily Living Impaired, Arthralgia, Xerosis, Grip Strength Decreased, Amyloidosis, Asthenia, Mobility Decreased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Magnevist
    Dosage: unk, once
    Indication: Angiogram
    Start date: 2006-07-17
    End date: 2006-07-17

Magnevist

Other drugs received by patient: Norvasc; Epogen; Iron; Oxycodone HCL; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Lebacarton; Sensipar; Corticosteroids



Possible Magnevist side effects in 63 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-29

Patient: 63 year old male, weighing 61.0 kg (134.2 pounds)

Reactions: Muscle Atrophy, Skin Exfoliation, Pain, Sensory Loss, Scleroderma, Pallor, Anhedonia, Joint Range of Motion Decreased, Skin Discolouration, Musculoskeletal Stiffness, Skin Atrophy, Extremity Contracture, Motor Dysfunction, Skin Disorder, Muscular Weakness, Skin Fragility, Nephrogenic Systemic Fibrosis, DRY Skin, Hypoaesthesia, Skin Induration, Anxiety, Burning Sensation, Emotional Distress, Activities of Daily Living Impaired, Arthralgia, Xerosis, Grip Strength Decreased, Amyloidosis, Asthenia, Mobility Decreased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Magnevist

Magnevist
    Dosage: unk, once
    Indication: Angiogram
    Start date: 2006-07-17
    End date: 2006-07-17

Other drugs received by patient: Sensipar; Norvasc; Iron; Corticosteroids; Oxycodone HCL; Lebacarton; Epogen; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]



Possible Magnevist side effects in 20 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-21

Patient: 20 year old male, weighing 48.6 kg (106.9 pounds)

Reactions: Skin Exfoliation, Hypertrophy, Joint Contracture, Pain, Abasia, Joint Range of Motion Decreased, Oedema Peripheral, Oedema, Depression, Joint Effusion, Extremity Contracture, Pain in Extremity, Nephrogenic Systemic Fibrosis, DRY Skin, Skin Tightness, Anxiety, Emotional Distress, Cachexia, Joint Warmth, Asthenia, Mobility Decreased

Adverse event resulted in: death, disablity

Drug(s) suspected as cause:
Magnevist
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2006-01-21
    End date: 2006-01-21

Omniscan
    Dosage: 30 ml, once
    Indication: Angiogram
    Start date: 2005-06-02
    End date: 2005-06-02

Omniscan

Other drugs received by patient: Enoxaparin; Labetalol HCL; Norvasc; Dantrolene Sodium; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Clonidine HCL; Darbepoetin Alfa; Hydralazine HCL; Fluoxetine; Cefazolin; Renagel; Coumadin



Possible Magnevist side effects in 63 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-21

Patient: 63 year old male, weighing 61.0 kg (134.2 pounds)

Reactions: Muscle Atrophy, Sensory Loss, Scleroderma, Vertebral Foraminal Stenosis, Fibrosis, Skin Atrophy, Hypoaesthesia, Skin Induration, Nephrogenic Systemic Fibrosis, Emotional Distress, Activities of Daily Living Impaired, Mobility Decreased, Renal Osteodystrophy, Skin Exfoliation, Pain, Pallor, Anhedonia, Joint Range of Motion Decreased, Skin Discolouration, Musculoskeletal Stiffness, Extremity Contracture, Motor Dysfunction, Skin Disorder, Skin Fragility, Muscular Weakness, DRY Skin, Anxiety, Burning Sensation, Arthralgia, Xerosis, Grip Strength Decreased, Amyloidosis, Peripheral Arterial Occlusive Disease, Spinal Osteoarthritis, Asthenia

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Magnevist
    Dosage: unk, once
    Indication: Angiogram
    Start date: 2006-07-17
    End date: 2006-07-17

Magnevist

Other drugs received by patient: Lebacarton; Sensipar; Epogen; Iron; Oxycodone HCL; Norvasc; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Corticosteroids



Possible Magnevist side effects in 63 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-15

Patient: 63 year old male, weighing 61.0 kg (134.2 pounds)

Reactions: Muscle Atrophy, Renal Osteodystrophy, Pain, Sensory Loss, Joint Deposit, Anhedonia, Joint Range of Motion Decreased, Musculoskeletal Stiffness, Fibrosis, Vertebral Foraminal Stenosis, Skin Atrophy, Motor Dysfunction, Muscular Weakness, Skin Fragility, Skin Disorder, Nephrogenic Systemic Fibrosis, Hypoaesthesia, Burning Sensation, Anxiety, Emotional Distress, Activities of Daily Living Impaired, Peripheral Arterial Occlusive Disease, Spinal Osteoarthritis, Asthenia, Mobility Decreased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Magnevist

Magnevist
    Dosage: unk, once
    Indication: Angiogram
    Start date: 2006-07-17
    End date: 2006-07-17

Other drugs received by patient: Lebacarton; Epogen; Corticosteroids; Oxycodone HCL; Sensipar; Norvasc; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Iron



Possible Magnevist side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-05

Patient: female, weighing 78.7 kg (173.1 pounds)

Reactions: Pain, Abasia, Skin Induration, Nephrogenic Systemic Fibrosis, Deformity, Skin Tightness, Emotional Distress, Anxiety, Skin Discolouration, Fibrosis, Coordination Abnormal, Mobility Decreased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Magnevist
    Indication: Imaging Procedure

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2008-02-25
    End date: 2008-02-25

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2004-06-04
    End date: 2004-06-04

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2002-08-24
    End date: 2002-08-24

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2004-07-16
    End date: 2004-07-16

Optimark
    Indication: Imaging Procedure

Multihance
    Indication: Imaging Procedure

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2005-05-25
    End date: 2005-05-25

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2008-06-04
    End date: 2008-06-04

Omniscan
    Indication: Imaging Procedure

Prohance
    Indication: Imaging Procedure

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2004-05-17
    End date: 2004-05-17

Other drugs received by patient: Venofer; Aranesp; Clonidine; Metoprolol Succinate; Altace; Coumadin; Atenolol; Renagel; Enalapril Maleate; Epogen; Norvasc; Renvela



Possible Magnevist side effects in 63 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-02

Patient: 63 year old male

Reactions: Renal Osteodystrophy, Pain, Skin Fragility, Nephrogenic Systemic Fibrosis, Emotional Distress, Anxiety, Anhedonia, Joint Range of Motion Decreased, Musculoskeletal Stiffness, Vertebral Foraminal Stenosis, Skin Atrophy, Mobility Decreased, Spondyloarthropathy

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Magnevist

Magnevist
    Dosage: unk, once
    Indication: Angiogram
    Start date: 2006-07-17
    End date: 2006-07-17

Other drugs received by patient: Norvasc; Sensipar; Epogen; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Oxycodone HCL; Lebacarton; Iron; Corticosteroid NOS



Possible Magnevist side effects in 63 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-22

Patient: 63 year old male

Reactions: Emotional Distress, Anxiety, Anhedonia, Joint Range of Motion Decreased, Pain, Musculoskeletal Stiffness, Nephrogenic Systemic Fibrosis, Mobility Decreased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Magnevist
    Dosage: unk, once
    Indication: Angiogram
    Start date: 2006-07-17
    End date: 2006-07-17

Magnevist

Other drugs received by patient: Oxycodone HCL; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Iron; Lebacarton; Sensipar; Epogen; Norvasc



Possible Magnevist side effects in 63 year old male

Reported by a consumer/non-health professional from United States on 2012-02-22

Patient: 63 year old male

Reactions: Emotional Distress, Anxiety, Anhedonia, Joint Range of Motion Decreased, Pain, Musculoskeletal Stiffness, Nephrogenic Systemic Fibrosis, Mobility Decreased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Magnevist

Magnevist
    Dosage: unk, once
    Indication: Angiogram
    Start date: 2006-07-17
    End date: 2006-07-17

Other drugs received by patient: Oxycodone HCL; Epogen; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Iron; Sensipar; Lebacarton; Norvasc



Possible Magnevist side effects in 56 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-01

Patient: 56 year old male, weighing 115.7 kg (254.4 pounds)

Reactions: Pain, Sensory Loss, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Skin Tightness, Pruritus Generalised, Skin Discolouration, Arthralgia, Joint Range of Motion Decreased, Musculoskeletal Stiffness, Depression, Gait Disturbance, Asthenia, Skin Fibrosis, Scar

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Magnevist
    Indication: Angiogram

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2003-11-11
    End date: 2003-11-11

Magnevist
    Dosage: 20 ml, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2004-04-20
    End date: 2004-04-20

Magnevist
    Start date: 2006-05-10
    End date: 2006-05-10

Multihance
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2007-08-22
    End date: 2007-08-22

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2003-11-05
    End date: 2003-11-05

Other drugs received by patient: Synthroid; Singulair; Prozac; Hydrochlorothiazide; Protonix; Diovan; Ambien; Alprazolam; Plavix; Furosemide; Lantus; Aggrenox; Lipitor; Tricor; Actos; Acetylsalicylic Acid SRT; Biaxin; Zocor; Avandia; Cyclobenzaprine; Celebrex; Advair Diskus 100 / 50; Prednisone TAB; Amaryl; Prevacid; Tramadol HCL; Zetia; Byetta



Possible Magnevist side effects in 41 year old female

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-01-25

Patient: 41 year old female

Reactions: Nephrogenic Systemic Fibrosis

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Magnevist
    Dosage: nr, single dose, intravenous
    Indication: Product Used FOR Unknown Indication
    Start date: 2007-10-01
    End date: 2007-10-01

Omniscan
    Dosage: 20 ml, single dose, intravenous
    Indication: Transplant Evaluation
    Start date: 2006-03-13
    End date: 2006-03-13

Gadovist (Gadobutrol)
    Dosage: nr, single dose, intravenous
    Indication: Arteriovenous Fistula
    Start date: 2009-09-01
    End date: 2009-09-01

Other drugs received by patient: Sevelamer (Renagel) (Sevelamer); Cinacalcet (Mimpara) (Cinacalcet); Metoclopramide (Emperal) (Metoclpramide Hydrochloride); Vitamin B Complex, Plain 9B-Combin Sterk) (B-Komplex); Saccharated Iron Oxide (Venofer) (Saccharated Iron Oxide); Tinzaparin (Innohep0 (Heparin-Fraction, Sodium Salt); Paracetamol (Pinex) (Paracetamol); Metoclopramide (Primperan) (Metoclopramide); Ramipril (Triatec) (Ramipril); Stolpidem (Stilnoct) (Zolpidem Tartrate); Labetalol (Trandate) (Labetalol Hydrochloride); Metoprolol (Selo-Zok) (Metoprolol Succinate); Clopidogrel (Plavix) (Clopidogrel); Vancomycin (Vancomycin ^hospira^) (Vancomycin); Codeine Sulfate; Atorvastatin; Ciprofloxacin; Tramadol (Tradolan) (Tramadol Hydrochloride); Paricalcitol (Zemplar) (Paricalcitol); Warfarin (Marevan) (Warfarin Sodium); Ketobemidone (Ketogan) (Ketogin); Excl. Psycholeptics (Fortamol) (Galenic / Paracetamol / Codeine / ); Folic Acid; Atorvastatin; Lanthanum Carbonate (Fosrenol) (Lanthanum Carbonate); Darbepoetin Alfa (Aranesp) (Darbepoetin Alfa); Glyceryl Trinitrate (Nitrolingual) (Glyceryl Trinitrate); Melatonin (Circadin) (Melatonin); Vitamin C (Nycoplus C) (Ascorbic Acid)



Possible Magnevist side effects in 41 year old female

Reported by a physician from Denmark on 2012-01-24

Patient: 41 year old female, weighing 45.0 kg (99.0 pounds)

Reactions: Pain, Skin Burning Sensation, Muscle Tightness, Joint Stiffness, Joint Range of Motion Decreased, Skin Discolouration, Balance Disorder, Oedema Peripheral, Musculoskeletal Stiffness, Muscle Contracture, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, Skin Induration, Ulcer, Skin Tightness, Spider Vein, Joint Swelling, Tendon Disorder, Gait Disturbance

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Magnevist
    Dosage: 469 mg/ml, unk
    Indication: Scan With Contrast
    Start date: 2007-10-01
    End date: 2007-10-01

Magnevist
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2007-01-01

Omniscan
    Dosage: 0,5 mmol/ml
    Indication: Angiogram
    Start date: 2006-03-13
    End date: 2006-03-13

Gadavist
    Dosage: 1 mmol/ml
    Indication: Scan With Contrast
    Start date: 2009-09-16
    End date: 2009-09-16

Gadavist
    Indication: Wound

Omniscan
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2007-10-01
    End date: 2007-10-01

Omniscan
    Dosage: unk
    Start date: 2006-01-01

Gadavist
    Dosage: unk
    Indication: Arteriovenous Fistula Operation
    Start date: 2009-09-01
    End date: 2009-09-01

Other drugs received by patient: Fosrenol; Atorvastatin; Vancomycin; Zemplar; Emperal; Vitamin B Complex CAP; Metoprolol Succinate; Warfarin Sodium; Zolpidem Tartrate; Ciprofloxacin; Aranesp; Vancomycin ^alpharma^; Folinsyre ^sad^; Codeine Sulfate; Ketogan Novum; Innohep; Primperan TAB; Circadin; Tramadol HCL; B-Combin; Renagel; Plavix; Mimpara [cinacalcet]; Trandate; Nycoplus C-Vitamin; Pinex; Venofer; Nitrolingual; Nitrolingual; Fortamol; Ramipril



Possible Magnevist side effects in 41 year old female

Reported by a physician from Denmark on 2012-01-24

Patient: 41 year old female, weighing 45.0 kg (99.0 pounds)

Reactions: Pain, Skin Burning Sensation, Muscle Tightness, Joint Stiffness, Joint Range of Motion Decreased, Balance Disorder, Skin Discolouration, Oedema Peripheral, Musculoskeletal Stiffness, Muscle Contracture, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Skin Induration, Ulcer, Skin Tightness, Spider Vein, Joint Swelling, Tendon Disorder, Gait Disturbance

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Gadavist
    Dosage: unk
    Indication: Arteriovenous Fistula Operation
    Start date: 2009-09-01
    End date: 2009-09-01

Omniscan
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2007-10-01
    End date: 2007-10-01

Omniscan
    Dosage: unk
    Start date: 2006-01-01

Magnevist
    Dosage: 469 mg/ml, unk
    Indication: Scan With Contrast
    Start date: 2007-10-01
    End date: 2007-10-01

Magnevist
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2007-01-01

Gadavist
    Indication: Nuclear Magnetic Resonance Imaging

Gadavist
    Dosage: 1 mmol/ml
    Indication: Scan With Contrast
    Start date: 2009-09-16
    End date: 2009-09-16

Omniscan
    Dosage: 0,5 mmol/ml
    Indication: Angiogram
    Start date: 2006-03-13
    End date: 2006-03-13

Other drugs received by patient: Emperal; Vitamin B Complex CAP; Ramipril; Folinsyre ^sad^; Primperan TAB; Ketogan Novum; Tramadol HCL; Plavix; Ciprofloxacin; Venofer; Aranesp; Pinex; Renagel; Innohep; Nitrolingual; B-Combin; Atorvastatin; Zolpidem Tartrate; Mimpara [cinacalcet]; Circadin; Vancomycin ^alpharma^; Nitrolingual; Codeine Sulfate; Metoprolol Succinate; Fosrenol; Vancomycin; Trandate; Warfarin Sodium; Zemplar; Fortamol; Nycoplus C-Vitamin



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012